Circulating FGF21 concentrations are elevated in patients with diastolic dysfunction and HFpEF, where higher levels correlate with increased filling pressures and impaired exercise capacity, suggesting a compensatory response or an acquired state of FGF21 resistance analogous to that seen in obesity and type 2 diabetes [59,60]. Here, FGF21 is linked to obesity disorder.